InsidersTradesSigma
Track the 엔지켐생명과학 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 엔지켐생명과학 has recorded 113 reports. Market capitalisation: €83.8bn. The latest transaction was reported on 1 June 2026 (Purchase). Among the most active insiders: 윤영배. The full history is openly available.
108
Insider Decl.
n/a
Thresholds
€3m
61 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,518 of 28,985 companies
8.7
score / 100
Value12
Quality6
FCF yld-14%
Earn yld-22%
EV/EBITDA·
ROE·
Gross mgn5.0%
Net mgn-27%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 June 2026
Declarations113 total
Other
Other
Other
Other
Other
1,105,852 sharesKRXDART:20260508001022
0KRXDART:20260420000485
0KRXDART:20260318000393
0KRXDART:20260311004127
6,625,447 sharesKRXDART:20260227008612
23,240 sharesKRXDART:20251202000228
0KRXDART:20241227000537
0KRXDART:20241108000392
0KRXDART:20240926000317
0KRXDART:20240812000689
0KRXDART:20240715000103
0KRXDART:20240702000407
25 of 113 declarations
About 엔지켐생명과학
엔지켐생명과학 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for disease treatment.